Alif Saleh, Scipher Medicine CEO

Pre­ci­sion im­munol­o­gy play­er bags $110M to fund its work on 'dis­ease sig­na­ture' tests

A Mass­a­chu­setts start­up is walk­ing away from its lat­est fi­nanc­ing haul with over $100 mil­lion in fresh cash, thanks to an in­vestor syn­di­cate back­ing their pur­suit of pa­tient re­sponse tests.

The $110 mil­lion round for Sci­pher Med­i­cine was led by Cowen Health­care In­vest­ments, and in­cludes ex­ist­ing big-name back­ers North­pond Ven­tures and Khosla Ven­tures — bring­ing Sci­pher’s to­tal fundrais­ing to $227 mil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Venture & Research Associate

Alexandria Real Estate Equities

San Francisco, CA, USA